The FDA approved a self-expanding stent system for patients with peripheral artery disease, adding another option for treating blockages in the iliac arteries.
Medtronic received the all-clear to market its Protégé GPS self-expanding peripheral stent system as a treatment for stenotic lesions of the common and external iliac arteries. The agency based its approval on the nonrandomized DURABILITY trial, which showed a 95.8 percent patency rate, according to Medtronic.
The system incorporates a self-expanding nitinol stent with GPS markers at the proximal and distal ends that are designed to facilitate positioning. The Protégé device is compatible with a 6 French profile delivery system.